-
1Electronic Resource
المؤلفون: Burge M., Segelov E., Tebbutt N.C., Reece W.H.H., Price T., Molloy M.P., Marx G., Jones K., Gibbs P., Feeney K., Clarke S.J.
مصطلحات الفهرس: intestine fistula/si [Side Effect], intestine perforation/si [Side Effect], large intestine perforation/si [Side Effect], lung embolism/si [Side Effect], major clinical study, male, metastatic colorectal cancer/dt [Drug Therapy], mucosa inflammation/si [Side Effect], multicenter study, multiple cycle treatment, nausea/si [Side Effect], neutropenia/si [Side Effect], neutrophil lymphocyte ratio, open study, overall survival, paresthesia/si [Side Effect], perianal abscess/si [Side Effect], peripheral neuropathy/si [Side Effect], phase 4 clinical trial, progression free survival, proteinuria/si [Side Effect], proteomics, rectum perforation/si [Side Effect], survival rate, treatment outcome, vomiting/si [Side Effect], bevacizumab/ae [Adverse Drug Reaction], bevacizumab/ct [Clinical Trial], bevacizumab/dt [Drug Therapy], capecitabine plus oxaliplatin/ct [Clinical Trial], capecitabine plus oxaliplatin/dt [Drug Therapy], proteome/ec [Endogenous Compound], capecitabine plus oxaliplatin/ae [Adverse Drug Reaction], abdominal pain/si [Side Effect], adult, aged, alopecia/si [Side Effect], anus fistula/si [Side Effect], article, cancer combination chemotherapy, cancer prognosis, carcinoma in situ/dt [Drug Therapy], constipation/si [Side Effect], controlled study, decreased appetite/si [Side Effect], diarrhea/si [Side Effect], digestive system perforation/si [Side Effect], drug safety, epistaxis/si [Side Effect], exploratory research, fatigue/si [Side Effect], female, gastroesophageal reflux/si [Side Effect], hand foot syndrome/si [Side Effect], human, hypertension/si [Side Effect], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29334
PLoS ONE
Click here for full text options
LibKey Link -
2Electronic Resource
المؤلفون: Burge M., Segelov E., Tebbutt N.C., Reece W.H.H., Price T., Molloy M.P., Marx G., Jones K., Gibbs P., Feeney K., Clarke S.J.
مصطلحات الفهرس: intestine fistula/si [Side Effect], intestine perforation/si [Side Effect], large intestine perforation/si [Side Effect], lung embolism/si [Side Effect], major clinical study, male, metastatic colorectal cancer/dt [Drug Therapy], mucosa inflammation/si [Side Effect], multicenter study, multiple cycle treatment, nausea/si [Side Effect], neutropenia/si [Side Effect], neutrophil lymphocyte ratio, open study, overall survival, paresthesia/si [Side Effect], perianal abscess/si [Side Effect], peripheral neuropathy/si [Side Effect], phase 4 clinical trial, progression free survival, proteinuria/si [Side Effect], proteomics, rectum perforation/si [Side Effect], survival rate, treatment outcome, vomiting/si [Side Effect], bevacizumab/ae [Adverse Drug Reaction], bevacizumab/ct [Clinical Trial], bevacizumab/dt [Drug Therapy], capecitabine plus oxaliplatin/ct [Clinical Trial], capecitabine plus oxaliplatin/dt [Drug Therapy], proteome/ec [Endogenous Compound], capecitabine plus oxaliplatin/ae [Adverse Drug Reaction], abdominal pain/si [Side Effect], adult, aged, alopecia/si [Side Effect], anus fistula/si [Side Effect], article, cancer combination chemotherapy, cancer prognosis, carcinoma in situ/dt [Drug Therapy], constipation/si [Side Effect], controlled study, decreased appetite/si [Side Effect], diarrhea/si [Side Effect], digestive system perforation/si [Side Effect], drug safety, epistaxis/si [Side Effect], exploratory research, fatigue/si [Side Effect], female, gastroesophageal reflux/si [Side Effect], hand foot syndrome/si [Side Effect], human, hypertension/si [Side Effect], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29334
PLoS ONE
LibKey Link -
3Electronic Resource
المؤلفون: Atkinson V., Haydon A., Millward M., Begbie S., Brown M., Markman B., Patterson W., Hill A., Horvath L., Nagrial A., Richardson G., Jackson C., Friedlander M., Parente P., Tran B., Wang L., Chen Y., Tang Z., Huang W., Wu J., Zeng D., Luo L., Solomon B., Desai J., Gan H., Barrow C., Jameson M.
مصطلحات الفهرس: endometrium cancer/di [Diagnosis], endometrium cancer/dt [Drug Therapy], endometrium cancer/et [Etiology], enzyme inhibition, fatigue/si [Side Effect], female, fever/si [Side Effect], gastroesophageal reflux/si [Side Effect], glossodynia/si [Side Effect], hand foot syndrome/si [Side Effect], headache/si [Side Effect], human, hyperkeratosis/si [Side Effect], hypertension/si [Side Effect], hypomagnesemia/si [Side Effect], hypophosphatemia/si [Side Effect], hypotension/si [Side Effect], insomnia/si [Side Effect], intestine obstruction/si [Side Effect], intestine perforation/si [Side Effect], lethargy/si [Side Effect], limb pain/si [Side Effect], major clinical study, male, maximum plasma concentration, maximum tolerated dose, melanoma/di [Diagnosis], melanoma/dt [Drug Therapy], melanoma/et [Etiology], multiple cycle treatment, muscle spasm/si [Side Effect], musculoskeletal chest pain/si [Side Effect], myalgia/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], non small cell lung cancer/di [Diagnosis], non small cell lung cancer/dt [Drug Therapy], non small cell lung cancer/et [Etiology], oncogene N ras, oropharynx pain/si [Side Effect], ovary cancer/di [Diagnosis], ovary cancer/dt [Drug Therapy], ovary cancer/et [Etiology], palmoplantar keratoderma/si [Side Effect], pericardial effusion/si [Side Effect], phase 1 clinical trial, photosensitivity/si [Side Effect], pleura effusion/si [Side Effect], positron emission tomography-computed tomography, priority journal, progression free survival, pruritus/si [Side Effect], QT prolongation/si [Side Effect], rash/si [Side Effect], sepsis/si [Side Effect], side effect/si [Side Effect], skin defect/si [Side Effect], skin hypertrophy/si [Side Effect], solid malignant neoplasm, thrombocytopenia/si [Side Effect], thrush/si [Side Effect], thyroid cancer/di [Diagnosis], thyroid cancer/dt [Drug Therapy], thyroid cancer/et [Etiology], thyroid papillary carcinoma/di [Diagnosis], thyroid papillary carcinoma/dt [Drug Therapy], thyroid papillary carcinoma/et [Etiology], treatment duration, upper abdominal pain/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], vomiting/si [Side Effect], xerostomia/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], B Raf kinase/ec [Endogenous Compound], K ras protein/ec [Endogenous Compound], lifirafenib/ae [Adverse Drug Reaction], lifirafenib/ct [Clinical Trial], lifirafenib/cr [Drug Concentration], lifirafenib/do [Drug Dose], lifirafenib/dt [Drug Therapy], lifirafenib/to [Drug Toxicity], lifirafenib/pd [Pharmacology], dizziness/si [Side Effect], abdominal pain/si [Side Effect], adult, aged, alanine aminotransferase blood level, anemia/si [Side Effect], antineoplastic activity, arthralgia/si [Side Effect], article, backache/si [Side Effect], blood level, blood toxicity/si [Side Effect], body weight disorder/si [Side Effect], body weight loss, brain hemorrhage/si [Side Effect], cancer chemotherapy, cancer patient, cancer radiotherapy, cancer staging, cancer survival, chill/si [Side Effect], cohort analysis, colorectal cancer/di [Diagnosis], colorectal cancer/dt [Drug Therapy], colorectal cancer/et [Etiology], constipation/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], dermatitis/si [Side Effect], diarrhea/si [Side Effect], disease exacerbation/si [Side Effect], drug blood level, drug dose increase, drug half life, drug safety, drug tolerability, dry skin/si [Side Effect], dysgeusia/si [Side Effect], dysphonia/si [Side Effect], dyspnea/si [Side Effect], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/28975
Journal of Clinical Oncology
Click here for full text options
LibKey Link -
4Electronic Resource
المؤلفون: Atkinson V., Haydon A., Millward M., Begbie S., Brown M., Markman B., Patterson W., Hill A., Horvath L., Nagrial A., Richardson G., Jackson C., Friedlander M., Parente P., Tran B., Wang L., Chen Y., Tang Z., Huang W., Wu J., Zeng D., Luo L., Solomon B., Desai J., Gan H., Barrow C., Jameson M.
مصطلحات الفهرس: endometrium cancer/di [Diagnosis], endometrium cancer/dt [Drug Therapy], endometrium cancer/et [Etiology], enzyme inhibition, fatigue/si [Side Effect], female, fever/si [Side Effect], gastroesophageal reflux/si [Side Effect], glossodynia/si [Side Effect], hand foot syndrome/si [Side Effect], headache/si [Side Effect], human, hyperkeratosis/si [Side Effect], hypertension/si [Side Effect], hypomagnesemia/si [Side Effect], hypophosphatemia/si [Side Effect], hypotension/si [Side Effect], insomnia/si [Side Effect], intestine obstruction/si [Side Effect], intestine perforation/si [Side Effect], lethargy/si [Side Effect], limb pain/si [Side Effect], major clinical study, male, maximum plasma concentration, maximum tolerated dose, melanoma/di [Diagnosis], melanoma/dt [Drug Therapy], melanoma/et [Etiology], multiple cycle treatment, muscle spasm/si [Side Effect], musculoskeletal chest pain/si [Side Effect], myalgia/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], non small cell lung cancer/di [Diagnosis], non small cell lung cancer/dt [Drug Therapy], non small cell lung cancer/et [Etiology], oncogene N ras, oropharynx pain/si [Side Effect], ovary cancer/di [Diagnosis], ovary cancer/dt [Drug Therapy], ovary cancer/et [Etiology], palmoplantar keratoderma/si [Side Effect], pericardial effusion/si [Side Effect], phase 1 clinical trial, photosensitivity/si [Side Effect], pleura effusion/si [Side Effect], positron emission tomography-computed tomography, priority journal, progression free survival, pruritus/si [Side Effect], QT prolongation/si [Side Effect], rash/si [Side Effect], sepsis/si [Side Effect], side effect/si [Side Effect], skin defect/si [Side Effect], skin hypertrophy/si [Side Effect], solid malignant neoplasm, thrombocytopenia/si [Side Effect], thrush/si [Side Effect], thyroid cancer/di [Diagnosis], thyroid cancer/dt [Drug Therapy], thyroid cancer/et [Etiology], thyroid papillary carcinoma/di [Diagnosis], thyroid papillary carcinoma/dt [Drug Therapy], thyroid papillary carcinoma/et [Etiology], treatment duration, upper abdominal pain/si [Side Effect], upper respiratory tract infection/si [Side Effect], urinary tract infection/si [Side Effect], vomiting/si [Side Effect], xerostomia/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], B Raf kinase/ec [Endogenous Compound], K ras protein/ec [Endogenous Compound], lifirafenib/ae [Adverse Drug Reaction], lifirafenib/ct [Clinical Trial], lifirafenib/cr [Drug Concentration], lifirafenib/do [Drug Dose], lifirafenib/dt [Drug Therapy], lifirafenib/to [Drug Toxicity], lifirafenib/pd [Pharmacology], dizziness/si [Side Effect], abdominal pain/si [Side Effect], adult, aged, alanine aminotransferase blood level, anemia/si [Side Effect], antineoplastic activity, arthralgia/si [Side Effect], article, backache/si [Side Effect], blood level, blood toxicity/si [Side Effect], body weight disorder/si [Side Effect], body weight loss, brain hemorrhage/si [Side Effect], cancer chemotherapy, cancer patient, cancer radiotherapy, cancer staging, cancer survival, chill/si [Side Effect], cohort analysis, colorectal cancer/di [Diagnosis], colorectal cancer/dt [Drug Therapy], colorectal cancer/et [Etiology], constipation/si [Side Effect], coughing/si [Side Effect], decreased appetite/si [Side Effect], dermatitis/si [Side Effect], diarrhea/si [Side Effect], disease exacerbation/si [Side Effect], drug blood level, drug dose increase, drug half life, drug safety, drug tolerability, dry skin/si [Side Effect], dysgeusia/si [Side Effect], dysphonia/si [Side Effect], dyspnea/si [Side Effect], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/28975
Journal of Clinical Oncology
LibKey Link -
5Electronic Resource
المؤلفون: Usmani S.Z., Oriol A., Karlin L., Cavo M., Rifkin R.M., Hayek F., Kirschner E., Bharany N., Overton L., Mannem S., Harroff A., Jain S., Roque T., McIntyre K., Yasencha C.K., Houck W., Schjesvold F., Yimer H.A., LeBlanc R., Takezako N., McCroskey R.D., Lim A.B.M., Suzuki K., Kosugi H., Grigoriadis G., Avivi I., Facon T., Jagannath S., Lonial S., Ghori R.U., Farooqui M.Z.H., Marinello P., San-Miguel J., Lim A., Walker T., Nicol A., Reece D., Elemary M., Boudreault Pedneault J.S., Attal M., Weisel K., Engelhardt M., Mackensen A., Quinn J., Cohen A., Magen-Nativ H., Benyamini N., Larocca A., Matsumoto M., Iida S., Ishikawa T., Kondo Y., Sunami K., Ando K., Teshima T., Chou T., Iwasaki H., Miki H., Matsumura I., Onishi Y., Izutsu K., Kizaki M., George A., Blacklock H., Simpson D., Waage A., Samoilova O., Nikitin E., Chagorova T., McDonald A., Patel M., Oriol Rocafiguera A., San Miguel Izquierdo J., Mateos M., Streetly M., Forsyth P., Jackson G., Jenkins S., Rifkin R., Yimer H., McCroskey R., Martincic D., Tarantolo S., Larson S., Faroun Y., Vaughn J., Baz R., Saylors G., Neppalli A., Raptis A., Fung H., Janosky M., Stevens D., Coleman M., Costa D., Cross S., Fanning S., Berges D.F., Harris T., Zackon I., Atanackovic D., Lee K., Oliff I., Lee W., Bensinger W., Lutzky J., Baron A.
مصطلحات الفهرس: pruritus/si [Side Effect], randomized controlled trial, rash/si [Side Effect], respiratory failure/si [Side Effect], rhabdomyolysis/si [Side Effect], sepsis/si [Side Effect], Stevens Johnson syndrome/si [Side Effect], survival analysis, systemic lupus erythematosus/si [Side Effect], toxic hepatitis/si [Side Effect], treatment duration, adrenal insufficiency/si [Side Effect], aged, anemia/si [Side Effect], article, backache/si [Side Effect], cardiopulmonary insufficiency/si [Side Effect], chromosome analysis, colitis/si [Side Effect], computer assisted tomography, constipation/si [Side Effect], controlled study, coughing/si [Side Effect], decreased appetite/si [Side Effect], dermatitis/si [Side Effect], diarrhea/si [Side Effect], disease exacerbation/si [Side Effect], drug efficacy, drug eruption/si [Side Effect], drug safety, drug withdrawal, dry skin/si [Side Effect], dyspnea/si [Side Effect], erythema/si [Side Effect], erythema multiforme/si [Side Effect], fatigue/si [Side Effect], female, fever/si [Side Effect], Food and Drug Administration, health care quality, heart arrest/si [Side Effect], heart failure/si [Side Effect], human, hypersensitivity/si [Side Effect], hyperthyroidism/si [Side Effect], hypokalemia/si [Side Effect], hypothyroidism/si [Side Effect], infusion related reaction/si [Side Effect], insomnia/si [Side Effect], insulin dependent diabetes mellitus/si [Side Effect], intestine ischemia/si [Side Effect], intestine perforation/si [Side Effect], kidney failure/si [Side Effect], low drug dose, lung embolism/si [Side Effect], major clinical study, male, mortality rate, multicenter study, multiple myeloma/dt [Drug Therapy], myasthenia gravis/si [Side Effect], myocarditis/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], nuclear magnetic resonance imaging, open study, overall survival, pancreatitis/si [Side Effect], peripheral edema/si [Side Effect], phase 3 clinical trial, pneumonia/si [Side Effect], positron emission tomography, priority journal, progression free survival, quality of life assessment, upper gastrointestinal bleeding/si [Side Effect], upper respiratory tract infection/si [Side Effect], vomiting/si [Side Effect], dexamethasone/ae [Adverse Drug Reaction], dexamethasone/ct [Clinical Trial], dexamethasone/cb [Drug Combination], dexamethasone/dt [Drug Therapy], dexamethasone/po [Oral Drug Administration], dexamethasone/pv [Special Situation for Pharmacovigilance], lenalidomide/ae [Adverse Drug Reaction], lenalidomide/ct [Clinical Trial], lenalidomide/cb [Drug Combination], lenalidomide/dt [Drug Therapy], lenalidomide/po [Oral Drug Administration], lenalidomide/pv [Special Situation for Pharmacovigilance], pembrolizumab/ae [Adverse Drug Reaction], pembrolizumab/ct [Clinical Trial], pembrolizumab/cb [Drug Combination], pembrolizumab/dt [Drug Therapy], pembrolizumab/iv [Intravenous Drug Administration], pembrolizumab/pv [Special Situation for Pharmacovigilance], Article
URL: Click here for full text options
LibKey Link -
6Electronic Resource
المؤلفون: Usmani S.Z., Oriol A., Karlin L., Cavo M., Rifkin R.M., Hayek F., Kirschner E., Bharany N., Overton L., Mannem S., Harroff A., Jain S., Roque T., McIntyre K., Yasencha C.K., Houck W., Schjesvold F., Yimer H.A., LeBlanc R., Takezako N., McCroskey R.D., Lim A.B.M., Suzuki K., Kosugi H., Grigoriadis G., Avivi I., Facon T., Jagannath S., Lonial S., Ghori R.U., Farooqui M.Z.H., Marinello P., San-Miguel J., Lim A., Walker T., Nicol A., Reece D., Elemary M., Boudreault Pedneault J.S., Attal M., Weisel K., Engelhardt M., Mackensen A., Quinn J., Cohen A., Magen-Nativ H., Benyamini N., Larocca A., Matsumoto M., Iida S., Ishikawa T., Kondo Y., Sunami K., Ando K., Teshima T., Chou T., Iwasaki H., Miki H., Matsumura I., Onishi Y., Izutsu K., Kizaki M., George A., Blacklock H., Simpson D., Waage A., Samoilova O., Nikitin E., Chagorova T., McDonald A., Patel M., Oriol Rocafiguera A., San Miguel Izquierdo J., Mateos M., Streetly M., Forsyth P., Jackson G., Jenkins S., Rifkin R., Yimer H., McCroskey R., Martincic D., Tarantolo S., Larson S., Faroun Y., Vaughn J., Baz R., Saylors G., Neppalli A., Raptis A., Fung H., Janosky M., Stevens D., Coleman M., Costa D., Cross S., Fanning S., Berges D.F., Harris T., Zackon I., Atanackovic D., Lee K., Oliff I., Lee W., Bensinger W., Lutzky J., Baron A.
مصطلحات الفهرس: pruritus/si [Side Effect], randomized controlled trial, rash/si [Side Effect], respiratory failure/si [Side Effect], rhabdomyolysis/si [Side Effect], sepsis/si [Side Effect], Stevens Johnson syndrome/si [Side Effect], survival analysis, systemic lupus erythematosus/si [Side Effect], toxic hepatitis/si [Side Effect], treatment duration, adrenal insufficiency/si [Side Effect], aged, anemia/si [Side Effect], article, backache/si [Side Effect], cardiopulmonary insufficiency/si [Side Effect], chromosome analysis, colitis/si [Side Effect], computer assisted tomography, constipation/si [Side Effect], controlled study, coughing/si [Side Effect], decreased appetite/si [Side Effect], dermatitis/si [Side Effect], diarrhea/si [Side Effect], disease exacerbation/si [Side Effect], drug efficacy, drug eruption/si [Side Effect], drug safety, drug withdrawal, dry skin/si [Side Effect], dyspnea/si [Side Effect], erythema/si [Side Effect], erythema multiforme/si [Side Effect], fatigue/si [Side Effect], female, fever/si [Side Effect], Food and Drug Administration, health care quality, heart arrest/si [Side Effect], heart failure/si [Side Effect], human, hypersensitivity/si [Side Effect], hyperthyroidism/si [Side Effect], hypokalemia/si [Side Effect], hypothyroidism/si [Side Effect], infusion related reaction/si [Side Effect], insomnia/si [Side Effect], insulin dependent diabetes mellitus/si [Side Effect], intestine ischemia/si [Side Effect], intestine perforation/si [Side Effect], kidney failure/si [Side Effect], low drug dose, lung embolism/si [Side Effect], major clinical study, male, mortality rate, multicenter study, multiple myeloma/dt [Drug Therapy], myasthenia gravis/si [Side Effect], myocarditis/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], nuclear magnetic resonance imaging, open study, overall survival, pancreatitis/si [Side Effect], peripheral edema/si [Side Effect], phase 3 clinical trial, pneumonia/si [Side Effect], positron emission tomography, priority journal, progression free survival, quality of life assessment, upper gastrointestinal bleeding/si [Side Effect], upper respiratory tract infection/si [Side Effect], vomiting/si [Side Effect], dexamethasone/ae [Adverse Drug Reaction], dexamethasone/ct [Clinical Trial], dexamethasone/cb [Drug Combination], dexamethasone/dt [Drug Therapy], dexamethasone/po [Oral Drug Administration], dexamethasone/pv [Special Situation for Pharmacovigilance], lenalidomide/ae [Adverse Drug Reaction], lenalidomide/ct [Clinical Trial], lenalidomide/cb [Drug Combination], lenalidomide/dt [Drug Therapy], lenalidomide/po [Oral Drug Administration], lenalidomide/pv [Special Situation for Pharmacovigilance], pembrolizumab/ae [Adverse Drug Reaction], pembrolizumab/ct [Clinical Trial], pembrolizumab/cb [Drug Combination], pembrolizumab/dt [Drug Therapy], pembrolizumab/iv [Intravenous Drug Administration], pembrolizumab/pv [Special Situation for Pharmacovigilance], Article
-
7Electronic Resource
المؤلفون: Sehgal A., McNamara P.J.
مصطلحات الفهرس: necrotizing enterocolitis/si [Side Effect], newborn morbidity, nonhuman, patent ductus arteriosus/di [Diagnosis], patent ductus arteriosus/su [Surgery], patent ductus arteriosus/dt [Drug Therapy], postoperative complication/co [Complication], prematurity, priority journal, randomized controlled trial (topic), review, risk factor, side effect/si [Side Effect], indometacin/ae [Adverse Drug Reaction], indometacin/ct [Clinical Trial], indometacin/dt [Drug Therapy], nonsteroid antiinflammatory agent/ct [Clinical Trial], nonsteroid antiinflammatory agent/dt [Drug Therapy], artery ligation, coronary artery blood flow, disease classification, disease marker, Doppler echography, ductus arteriosus, echocardiography, human, intestine perforation/et [Etiology], intestine perforation/si [Side Effect], kidney disease/si [Side Effect], necrotizing enterocolitis/dt [Drug Therapy], necrotizing enterocolitis/et [Etiology], Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/28360
Click here for full text options
LibKey Link -
8Electronic Resource
المؤلفون: Sehgal A., McNamara P.J.
مصطلحات الفهرس: necrotizing enterocolitis/si [Side Effect], newborn morbidity, nonhuman, patent ductus arteriosus/di [Diagnosis], patent ductus arteriosus/su [Surgery], patent ductus arteriosus/dt [Drug Therapy], postoperative complication/co [Complication], prematurity, priority journal, randomized controlled trial (topic), review, risk factor, side effect/si [Side Effect], indometacin/ae [Adverse Drug Reaction], indometacin/ct [Clinical Trial], indometacin/dt [Drug Therapy], nonsteroid antiinflammatory agent/ct [Clinical Trial], nonsteroid antiinflammatory agent/dt [Drug Therapy], artery ligation, coronary artery blood flow, disease classification, disease marker, Doppler echography, ductus arteriosus, echocardiography, human, intestine perforation/et [Etiology], intestine perforation/si [Side Effect], kidney disease/si [Side Effect], necrotizing enterocolitis/dt [Drug Therapy], necrotizing enterocolitis/et [Etiology], Review
-
9Electronic Resource
المؤلفون: Howard J., Parker S., Welby S., Page F., Corker M., Wykes R., Goss C., Whitney S., Oates J., Soulis E., Hoque M., Gebbie C., Tebbutt N.C., Wilson K., Gebski V.J., Cummins M.M., Zannino D., Van Hazel G.A., Robinson B., Broad A., Ganju V., Ackland S.P., Forgeson G., Cunningham D., Saunders M.P., Stockler M.R., Chua Y., Zalcberg J.R., Simes R.J., Price T.J., Price T., Coates A., O'Connell D., Brown C., Hague W., France A., Hicks S., James R., Masson R., O'Connell R., Pike R., Shoulder J., Stevens L., Tunney V., Vachan B., Wong N., Ackland S., Moylan E., Strickland A., Abdi E., Ransom D., Lowenthal R., Marx G., Nayagam S.S., Shannon J., Goldstein D., Karapetis C., Blum R., Eek R., Ward R., Pavlakis N., Wilcken N., Burns I., Wyld D., Underhill C., Claringbold P., Liauw W., Clingan P., Jefford M., Horvath L., McKendrick J., Chong G., Boyce A., Cassidy J., Kirsten F., Clarke S., Guo Y., Innes-Rowe J., Smith A., Williams J., Tournier E., Maliepaard S., Vitullo E., Humm G., Nguyen V., Midolo P., Chorlton C., McDonald L., Oliver L., Sjursen A.-M., Inglis C., Marafioti T., McCourt J., Richards A., Provis A., Rundle A., Whatman A., Emmett L., Raymond B., Byrne S., Withers E., Campbell J., Hodgkins C., Szwajcer M.
مصطلحات الفهرس: colorectal cancer/dt [Drug Therapy], diarrhea/si [Side Effect], fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], female, hand foot syndrome/si [Side Effect], hemolytic uremic syndrome/si [Side Effect], human, hypertension/si [Side Effect], infection/si [Side Effect], intestine perforation/si [Side Effect], major clinical study, male, metastasis/dt [Drug Therapy], multicenter study, nausea/si [Side Effect], neutropenia/si [Side Effect], New Zealand, overall survival, phase 3 clinical trial, priority journal, progression free survival, proteinuria/si [Side Effect], quality of life, randomized controlled trial, side effect/si [Side Effect], stomatitis/si [Side Effect], thrombocytopenia/si [Side Effect], thromboembolism/si [Side Effect], treatment response, United Kingdom, vein embolism/si [Side Effect], vein thrombosis/si [Side Effect], vomiting/si [Side Effect], bevacizumab/ae [Adverse Drug Reaction], bevacizumab/ct [Clinical Trial], bevacizumab/cb [Drug Combination], bevacizumab/cm [Drug Comparison], bevacizumab/dt [Drug Therapy], capecitabine/ae [Adverse Drug Reaction], capecitabine/ct [Clinical Trial], capecitabine/cb [Drug Combination], capecitabine/cm [Drug Comparison], capecitabine/dt [Drug Therapy], mitomycin/ae [Adverse Drug Reaction], Australia, mitomycin/cb [Drug Combination], mitomycin/cm [Drug Comparison], mitomycin/dt [Drug Therapy], bleeding/si [Side Effect], mitomycin/ct [Clinical Trial], adult, aged, article, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/30424
Journal of Clinical Oncology
Click here for full text options
LibKey Link -
10Electronic Resource
المؤلفون: Howard J., Parker S., Welby S., Page F., Corker M., Wykes R., Goss C., Whitney S., Oates J., Soulis E., Hoque M., Gebbie C., Tebbutt N.C., Wilson K., Gebski V.J., Cummins M.M., Zannino D., Van Hazel G.A., Robinson B., Broad A., Ganju V., Ackland S.P., Forgeson G., Cunningham D., Saunders M.P., Stockler M.R., Chua Y., Zalcberg J.R., Simes R.J., Price T.J., Price T., Coates A., O'Connell D., Brown C., Hague W., France A., Hicks S., James R., Masson R., O'Connell R., Pike R., Shoulder J., Stevens L., Tunney V., Vachan B., Wong N., Ackland S., Moylan E., Strickland A., Abdi E., Ransom D., Lowenthal R., Marx G., Nayagam S.S., Shannon J., Goldstein D., Karapetis C., Blum R., Eek R., Ward R., Pavlakis N., Wilcken N., Burns I., Wyld D., Underhill C., Claringbold P., Liauw W., Clingan P., Jefford M., Horvath L., McKendrick J., Chong G., Boyce A., Cassidy J., Kirsten F., Clarke S., Guo Y., Innes-Rowe J., Smith A., Williams J., Tournier E., Maliepaard S., Vitullo E., Humm G., Nguyen V., Midolo P., Chorlton C., McDonald L., Oliver L., Sjursen A.-M., Inglis C., Marafioti T., McCourt J., Richards A., Provis A., Rundle A., Whatman A., Emmett L., Raymond B., Byrne S., Withers E., Campbell J., Hodgkins C., Szwajcer M.
مصطلحات الفهرس: colorectal cancer/dt [Drug Therapy], diarrhea/si [Side Effect], fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], female, hand foot syndrome/si [Side Effect], hemolytic uremic syndrome/si [Side Effect], human, hypertension/si [Side Effect], infection/si [Side Effect], intestine perforation/si [Side Effect], major clinical study, male, metastasis/dt [Drug Therapy], multicenter study, nausea/si [Side Effect], neutropenia/si [Side Effect], New Zealand, overall survival, phase 3 clinical trial, priority journal, progression free survival, proteinuria/si [Side Effect], quality of life, randomized controlled trial, side effect/si [Side Effect], stomatitis/si [Side Effect], thrombocytopenia/si [Side Effect], thromboembolism/si [Side Effect], treatment response, United Kingdom, vein embolism/si [Side Effect], vein thrombosis/si [Side Effect], vomiting/si [Side Effect], bevacizumab/ae [Adverse Drug Reaction], bevacizumab/ct [Clinical Trial], bevacizumab/cb [Drug Combination], bevacizumab/cm [Drug Comparison], bevacizumab/dt [Drug Therapy], capecitabine/ae [Adverse Drug Reaction], capecitabine/ct [Clinical Trial], capecitabine/cb [Drug Combination], capecitabine/cm [Drug Comparison], capecitabine/dt [Drug Therapy], mitomycin/ae [Adverse Drug Reaction], Australia, mitomycin/cb [Drug Combination], mitomycin/cm [Drug Comparison], mitomycin/dt [Drug Therapy], bleeding/si [Side Effect], mitomycin/ct [Clinical Trial], adult, aged, article, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/30424
Journal of Clinical Oncology
LibKey Link -
11Electronic Resource
المؤلفون: Jamsen K., Sankaran K., Hiller J., Sinclair J.C., Lumley J., Doyle L.W., Davis P.G., Morley C.J., McPhee A., Carlin J.B., Kaimakamis M., Callanan C., Yu V., Hayes M., Li R., Fraser S., Gill A., Lontis R., Goodchild L., French N., Evans N., Reid S., Darlow B., Kuschel C., Alvaro R., Chiu A.
مصطلحات الفهرس: dexamethasone sodium phosphate/cm [Drug Comparison], article, artificial ventilation, blood pressure, clinical trial, controlled clinical trial, controlled study, drug dose reduction, extremely low birth weight/dt [Drug Therapy], extremely low birth weight/th [Therapy], extubation, gastrointestinal hemorrhage/si [Side Effect], glucose blood level, human, infant, intestine perforation/si [Side Effect], major clinical study, mortality, multicenter study, multiple cycle treatment, oxygen consumption, prematurity/dt [Drug Therapy], prematurity/th [Therapy], priority journal, randomized controlled trial, side effect/si [Side Effect], weight change, dexamethasone sodium phosphate/ae [Adverse Drug Reaction], dexamethasone sodium phosphate/ct [Clinical Trial], dexamethasone sodium phosphate/dt [Drug Therapy], glucose/ec [Endogenous Compound], placebo, sodium chloride/cm [Drug Comparison], Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/31938
Click here for full text options
LibKey Link -
12Electronic Resource
المؤلفون: Jamsen K., Sankaran K., Hiller J., Sinclair J.C., Lumley J., Doyle L.W., Davis P.G., Morley C.J., McPhee A., Carlin J.B., Kaimakamis M., Callanan C., Yu V., Hayes M., Li R., Fraser S., Gill A., Lontis R., Goodchild L., French N., Evans N., Reid S., Darlow B., Kuschel C., Alvaro R., Chiu A.
مصطلحات الفهرس: dexamethasone sodium phosphate/cm [Drug Comparison], article, artificial ventilation, blood pressure, clinical trial, controlled clinical trial, controlled study, drug dose reduction, extremely low birth weight/dt [Drug Therapy], extremely low birth weight/th [Therapy], extubation, gastrointestinal hemorrhage/si [Side Effect], glucose blood level, human, infant, intestine perforation/si [Side Effect], major clinical study, mortality, multicenter study, multiple cycle treatment, oxygen consumption, prematurity/dt [Drug Therapy], prematurity/th [Therapy], priority journal, randomized controlled trial, side effect/si [Side Effect], weight change, dexamethasone sodium phosphate/ae [Adverse Drug Reaction], dexamethasone sodium phosphate/ct [Clinical Trial], dexamethasone sodium phosphate/dt [Drug Therapy], glucose/ec [Endogenous Compound], placebo, sodium chloride/cm [Drug Comparison], Article